{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:39:37Z","timestamp":1788925177633,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGD24C080001"],"award-info":[{"award-number":["LTGD24C080001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277108"],"award-info":[{"award-number":["22277108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118463","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:07:18Z","timestamp":1765422438000},"page":"118463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine derivatives as cathepsin L inhibitor for the treatment of acute lung injury"],"prefix":"10.1016","volume":"303","author":[{"given":"Zhengtong","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-1374","authenticated-orcid":false,"given":"Qiwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-7600","authenticated-orcid":false,"given":"Xingxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118463_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute lung injury review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-020-0647-z","article-title":"Optimal mean airway pressure during high-frequency oscillatory ventilation in an experimental model of acute respiratory distress syndrome: EIT-based method","volume":"10","author":"Liu","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.ejmech.2025.118463_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/rccm.201609-1767CI","article-title":"Fifty years of research in ARDS. Is acute respiratory distress syndrome a preventable disease?","volume":"195","author":"Yadav","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajem.2021.04.006","article-title":"Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department","volume":"48","author":"Oduncu","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib5","first-page":"282","article-title":"Definition and epidemiology of acute respiratory distress syndrome, ann. Transl","volume":"5","author":"Rezoagli","year":"2017","journal-title":"Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: advances in diagnosis and treatment","volume":"319","author":"Fan","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.118463_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.201112-2132OC","article-title":"Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury","volume":"186","author":"Dhaliwal","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1165\/rcmb.2012-0406OC","article-title":"Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury","volume":"49","author":"Martinez-Gonzalez","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118463_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00786-2018","article-title":"Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury","volume":"53","author":"Park","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.118463_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2014.02.010","article-title":"Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats","volume":"153","author":"Tsai","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.118463_bib11","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00134-020-06296-9","article-title":"Phenotypes and personalized medicine in the acute respiratory distress syndrome","volume":"46","author":"Matthay","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110643","article-title":"Drug repurposing of anti-infective clinical drugs: discovery of two potential anti-cytokine storm agents","volume":"131","author":"Su","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118463_bib13","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1021\/acs.jmedchem.0c00626","article-title":"Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"63","author":"Choudhry","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib14","article-title":"Repurposing fostamatinib to combat SARS-CoV-2-Induced acute lung injury","volume":"1","author":"Tabassum","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejmech.2025.118463_bib15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.7150\/thno.30972","article-title":"A novel TNF-alpha-Targeting aptamer for TNF-alpha-Mediated acute lung injury and acute liver failure","volume":"9","author":"Lai","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2025.118463_bib16","article-title":"Saponins from Allium macrostemon bulbs attenuate endothelial inflammation and acute lung injury via the NF-kappaB\/VCAM-1 pathway","volume":"29","author":"Liu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118463_bib17","article-title":"HSF1 protects sepsis-induced acute lung injury by inhibiting NLRP3 inflammasome activation","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118463_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152753","article-title":"Evaluation of the anti-inflammatory effects of PI3Kdelta\/gamma inhibitors for treating acute lung injury","volume":"228","author":"Xiong","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejmech.2025.118463_bib19","article-title":"Vitamin K2 (MK-7) attenuates LPS-Induced acute lung injury via inhibiting inflammation, apoptosis, and ferroptosis","volume":"18","author":"Wang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118463_bib20","article-title":"Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118463_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104980","article-title":"Quassinoids from Brucea javanica and attenuates lipopolysaccharide-induced acute lung injury by inhibiting PI3K\/Akt\/NF-kappaB pathways","volume":"153","author":"He","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118463_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119192","article-title":"GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRbeta\/Akt\/NF-kappaB\/NLRP3 pathway","volume":"271","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118463_bib23","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1021\/acs.jmedchem.3c00832","article-title":"Discovery of the diphenyl 6-Oxo-1,6-dihydropyridazine-3-carboxylate\/carboxamide analogue J27 for the treatment of acute lung injury and sepsis by targeting JNK2 and inhibiting the JNK2-NF-kappaB\/MAPK pathway","volume":"66","author":"Liao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12906-021-03458-0","article-title":"Sinoacutine inhibits inflammatory responses to attenuates acute lung injury by regulating NF-kappaB and JNK signaling pathways","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.ejmech.2025.118463_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106219","article-title":"Fibroblast growth factor 21 dependent TLR4\/MYD88\/NF-kappaB signaling activation is involved in lipopolysaccharide-induced acute lung injury","volume":"80","author":"Gao","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118463_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106351","article-title":"Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK\/NF-kappaB pathways and acute lung injury in vivo","volume":"132","author":"Pei","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115697","article-title":"Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK\/NF-kappaB\/NLRP3 pathway","volume":"259","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110021","article-title":"Eriocitrin attenuates sepsis-induced acute lung injury in mice by regulating MKP1\/MAPK pathway mediated-glycolysis","volume":"118","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118463_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112221","article-title":"The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects","volume":"135","author":"Cao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118463_bib30","article-title":"Daphnetin ameliorates acute lung injury in mice with severe acute pancreatitis by inhibiting the JAK2-STAT3 pathway","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118463_bib31","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1021\/acs.jmedchem.3c00508","article-title":"Discovery of highly selective and orally bioavailable PI3Kdelta inhibitors with anti-inflammatory activity for treatment of acute lung Injury","volume":"66","author":"Tang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113804","article-title":"Memantine nitrate MN-08 suppresses NLRP3 inflammasome activation to protect against sepsis-induced acute lung injury in mice","volume":"156","author":"Hu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118463_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2147\/DDDT.S444408","article-title":"Dynasore alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis","volume":"18","author":"Shan","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejmech.2025.118463_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112660","article-title":"Recent developments of small molecules with anti-inflammatory activities for the treatment of acute lung injury","volume":"207","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112438","article-title":"Recent advancements in the development of heterocyclic anti-inflammatory agents","volume":"200","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113766","article-title":"Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury","volume":"225","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111024","article-title":"Inhibition of cathepsin L ameliorates inflammation through the A20\/NF-kappaB pathway in endotoxin-induced acute lung injury","volume":"27","author":"Yang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2025.118463_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acs.jmedchem.4c02030","article-title":"Design, synthesis, and biological evaluation of 2-Arylaminopyrimidine derivatives as dual cathepsin L and JAK inhibitors for the treatment of acute lung injury","volume":"68","author":"Shen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115648","article-title":"A novel indazole derivative, compound Cyy-272, attenuates LPS-Induced acute lung injury by inhibiting JNK phosphorylation","volume":"428","author":"Liu","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118463_bib40","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib41","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1021\/acs.jmedchem.3c00197","article-title":"Targeting receptor-interacting protein kinase 1 by novel benzothiazole derivatives: treatment of acute lung injury through the necroptosis pathway","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020741","article-title":"Amino derivatives of diaryl pyrimidines and azolopyrimidines as protective agents against LPS-induced acute lung injury","volume":"28","author":"Spasov","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118463_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14756366.2019.1618291","article-title":"Design and synthesis of novel pyrazolo[4,3-d]pyrimidines as potential therapeutic agents for acute lung injury","volume":"34","author":"Wang","year":"2019","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib44","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1021\/acs.jmedchem.3c02229","article-title":"Design, synthesis, and pharmacological evaluation of Spiro[carbazole-3,3'-pyrrolidine] derivatives as cGAS inhibitors for treatment of acute lung injury","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib45","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.12998\/wjcc.v12.i23.5374","article-title":"Impact of interleukin 6 levels on acute lung injury risk and disease severity in critically ill sepsis patients","volume":"12","author":"Liu","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ejmech.2025.118463_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2025.118463_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12487","article-title":"Cathepsin B regulates non-canonical NLRP3 inflammasome pathway by modulating activation of caspase-11 in kupffer cells","volume":"51","author":"Chen","year":"2018","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejmech.2025.118463_bib48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118463_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:45:43Z","timestamp":1781325943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0223523425012280"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118463","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine derivatives as cathepsin L inhibitor for the treatment of acute lung injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118463"}}